Clinical trial
Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced…
NCT00049348 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00049348 |
|---|---|
| Title | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer |
| Official title | A Randomized Phase II Study Of Gemcitabine Plus Radiotherapy Vs. Gemcitabine, 5-Fluorouracil And Cisplatin Followed By Radiotherapy And 5-Fluoraracil For Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | epoetin alfa, filgrastim, cisplatin, fluorouracil, gemcitabine hydrochloride, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy |
| Start date | Oct 13, 2003 |
| Primary completion | Oct 1, 2005 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: